Literatur
Boari N, Gagliardi F, Castellazzi P, Mortini P (2011) Surgical treatment of orbital cavernomas: clinical and functional outcome in a series of 20 patients. Acta Neurochir 153:491–498
Logan P, Bernabeu M, Ferreira A, Burnier MN Jr (2015) Evidence for the role of blue light in the development of uveal melanoma. J Ophthalmol 2015:1–7
Rishi P, Koundanya VV, Shields CL (2015) Using risk factors for detection and prognostication of uveal melanoma. Indian J Ophthalmol 63(2):110–116
Keshazare SH, Masoudi SF, Rasouli SF (2014) Effects of defining realistic compositions of the ocular melanoma on proton therapy. J Biomed Phys Eng 4(4):141–150
Carvajal RD, Schwartz GK, Mann H, Smith I, Nathan PD (2015) Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT). BMC Cancer 15:467
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
N. C. Pausch, I. Sterker und U. Bauer geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
F. Bootz, Bonn
Rights and permissions
About this article
Cite this article
Pausch, N.C., Sterker, I. & Bauer, U. Maligner intraorbitaler Tumor: Primum oder Metastase?. HNO 64, 262–264 (2016). https://doi.org/10.1007/s00106-016-0139-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-016-0139-5